Wednesday, June 29, 2016 11:50:26 AM
The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has bounced beautifully off of double bottom support at $240 on the daily chart. Today it traded as high as $254.70, just two days after hitting $240.00.
Investors are wondering if it is safe to buy the $IBB? The short answer is... no. This is why...
There is a major concern on the daily chart of the biotech ETF IBB. Notice the confirmed break down that took place when the IBB broke through the upsloping trend line. Once confirmed, a retrace into that trend line (like we are seeing today) is almost always a heavy shorting opportunity. That means the IBB may fall sharply as early as next week. If the IBB is falling hard, you can bet the market is dropping sharply. This should be a major concern to not only biotech investors but all investors in the stock market. Note the chart below...
Chart: https://verifiedinvesting.com/uploads/files/IBB06.29.2016.JPG
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM